MRUS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MRUS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-08), the Forward Annual Dividend Yield of Merus NV is 0.00%.
As of today (2024-06-08), the Trailing Annual Dividend Yield of Merus NV is 0.00%.
Merus NV's Dividends per Share for the three months ended in Mar. 2024 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
For the Biotechnology subindustry, Merus NV's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Merus NV's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Merus NV's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Merus NV (NAS:MRUS) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.
Thank you for viewing the detailed overview of Merus NV's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Harry Shuman | officer: Chief Accounting Officer | C/O MERUS N.V., VALELAAN 62, UTRECHT P7 3584 CM |
Peter B. Silverman | officer: EVP & General Counsel | C/O MERUS N.V., YALELAAN 62, UTRECHT P7 3584 CM |
Sven Ante Lundberg | director, officer: President, CEO & PFO | C/O CRISPR THERAPEUTICS AG, 200 SIDNEY STREET, CAMBRIDGE MA 02139 |
Biotechnology Value Fund L P | other: See Explanation of Responses | 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
Kruif John De | officer: Chief Technology Officer | C/O MERUS N.V., YALELAAN 62, UTRECHT P7 3584 CM |
Paolo Pucci | director | C/O ARQULE, INC., 1 WALL STREET, 6TH FLOOR, BURLINGTON MA 01803 |
Len Kanavy | director | C/O MERUS N.V., VALELAAN 62, UTRECHT P7 3584 CM |
Maxine Gowen | director | |
Anand Mehra | director | 3000 SAND HILL ROAD, 4-250, MENLO PARK CA 94025 |
Victor Sandor | director | C/O ARRAY BIOPHARMA INC., 3200 WALNUT STREET, BOULDER CO 80301 |
Mark T Iwicki | director | 84 WATERFORD DRIVE, MARLBOROUGH MA 01752 |
Gregory D Perry | director | C/O IMMUNOGEN, INC., 830 WINTER ST., WALTHAM MA 02451 |
Geuijen Cecile A W | officer: SVP & Chief Scientific Officer | C/O MERUS N.V., YALELAAN 62, UTRECHT P7 3584CM |
Andrew Joe | officer: SVP, CMO | C/O MERUS N.V., VALELAAN 62, UTRECHT P7 3584 CM |
Mark Throsby | officer: EVP & Chief Scientific Officer | C/O MERUS N.V., YALELAAN 62, UTRECHT P7 3584 CM |
From GuruFocus
By Stock market mentor Stock market mentor • 01-08-2023
By GuruFocus Research • 09-07-2023
By Marketwired • 10-06-2023
By Value_Insider Value_Insider • 10-26-2022
By GlobeNewswire GlobeNewswire • 01-08-2023
By sperokesalga sperokesalga • 04-17-2023
By Value_Insider Value_Insider • 11-09-2022
By GlobeNewswire • 11-26-2023
By Marketwired • 10-23-2023
By Stock market mentor Stock market mentor • 01-09-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.